Fast-acting insulin in snail venom

被引：0
|
作者：
Le Bras, Alexandra
机构：
[1] Lab Animal,
来源：
LAB ANIMAL | 2019年 / 48卷 / 04期
关键词：
D O I：
10.1038/s41684-019-0278-x
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
[No abstract available]
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [41] Biomonitoring Fast-acting antibody biosensor
    Houlton, Sarah
    CHEMISTRY & INDUSTRY, 2011, (10) : 6 - 6
  • [42] FAST-ACTING TRANSISTOR-AMPLIFIER
    LEGKII, VN
    KACHEV, LE
    INSTRUMENTS AND EXPERIMENTAL TECHNIQUES, 1983, 26 (02) : 373 - 374
  • [43] Tambjamines as Fast-Acting Multistage Antimalarials
    Kumar, Amrendra
    Li, Yuexin
    Dodean, Rozalia A.
    Roth, Alison
    Caridha, Diana
    Madejczyk, Michael S.
    Jin, Xiannu
    Dennis, William E.
    Lee, Patricia J.
    Pybus, Brandon S.
    Martin, Monica
    Pannone, Kristina
    Dinh, Hieu T.
    Blount, Cameron
    Chetree, Ravi
    Deluca, Jesse
    Evans, Martin
    Nadeau, Robert
    Vuong, Chau
    Leed, Susan
    Black, Chad
    Sousa, Jason
    Nolan, Christina
    Ceja, Frida G.
    Rasmussen, Stephanie A.
    Tumwebaze, Patrick K.
    Rosenthal, Philip J.
    Cooper, Roland A.
    Rottmann, Matthias
    Orjuela-Sanchez, Pamela
    Meister, Stephan
    Winzeler, Elizabeth A.
    Delves, Michael J.
    Matthews, Holly
    Baum, Jake
    Kirby, Robert W.
    Burrows, Jeremy N.
    Duffy, James
    Peyton, David H.
    Reynolds, Kevin A.
    Kelly, Jane X.
    Kancharla, Papireddy
    ACS INFECTIOUS DISEASES, 2024, 10 (12): : 4291 - 4300
  • [44] Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes
    Raskin, P
    Riis, A
    Guthrie, RA
    Jovanovic, L
    Leiter, L
    DIABETES CARE, 2000, 23 (05) : 583 - 588
  • [45] Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy
    Heller, SR
    Amiel, SA
    Mansell, P
    DIABETES CARE, 1999, 22 (10) : 1607 - 1611
  • [46] Efficacy and safety of fast-acting insulin aspart in adults with type 2 diabetes with different insulin requirements
    Sesti, G.
    Lane, W.
    Ekelund, M.
    Thorisdottir, O.
    Jodar, E.
    Oviedo, A.
    Rathor, N.
    Senior, P.
    Franek, E.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S330 - S330
  • [47] Evaluation of the fast-acting insulin analog (Lispro), subcutaneously, in the treatment of diabetic ketoacidosis (DKA)
    Della Manna, T
    Damiani, D
    Steinmetz, L
    Campos, PR
    Silva, AC
    Lima, SC
    Setian, N
    PEDIATRIC RESEARCH, 2004, 55 (04) : 135A - 135A
  • [48] FAST-ACTING INSULIN ASPART: A REVIEW OF ITS PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES AND THE CLINICAL CONSEQUENCES
    Haahr, Hanne
    Heise, Tim
    DIABETES MELLITUS, 2020, 23 (02): : 140 - 160
  • [49] Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences
    Haahr, Hanne
    Heise, Tim
    CLINICAL PHARMACOKINETICS, 2020, 59 (02) : 155 - 172
  • [50] Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions
    Hoevelmann, Ulrike
    Heise, Tim
    Nosek, Leszek
    Sassenfeld, Bettina
    Thomsen, Karen Margrete Due
    Haahr, Hanne
    CLINICAL DRUG INVESTIGATION, 2017, 37 (05) : 503 - 509
12345